Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort.
Maternal antibodies
Passive immunization
Respiratory syncytial virus
Transplacental antibody transfer
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
25
12
2019
accepted:
05
02
2020
pubmed:
16
2
2020
medline:
3
2
2021
entrez:
16
2
2020
Statut:
ppublish
Résumé
RSV is one of the most important agents of lower respiratory infections in childhood. In this study, anti-RSV antibody levels in mother-infant pairs and factors related to antibody transfer ratio were investigated. One hundred and twenty-seven women that had term babies and their babies and 84 mother-infant pairs of them who continued the study after 6 months were enrolled. Anti-RSV IgG antibodies of the mothers and infants were positive in 46.5% and 61.5%, respectively. At the sixth month, anti-RSV antibodies were negative in all infants. Median of the anti-RSV antibody levels of the mothers and infants at birth were 12.08 IU/ml (1.21-119.27) and 13.78 IU/ml (3.99-108.6), respectively. There was a significant correlation between anti-RSV antibody levels of mothers and infants at birth (p: 0.0001, r: 0.667) and anti-RSV antibody levels of infants at birth and at 6th month (p: 0.0001, r: 0.343). Median ratio of infant and mother antibody levels was 1.22 (0.14-6.05). Median ratio that was detected in appropriate for gestational age infants was significantly higher than in small for gestational age or large for gestational age infants. In this study, the significant positive correlation between maternal antibody levels and infants' antibody levels at birth suggests that maternal vaccination strategies may be logical. We showed that antibody transfer rate was highest in appropriate for gestational age infants. It should be kept in mind that maternal vaccination strategies may be less effective in small for gestational age and large for gestational age infants.
Identifiants
pubmed: 32060753
doi: 10.1007/s10096-020-03841-8
pii: 10.1007/s10096-020-03841-8
pmc: PMC7223508
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1279-1286Subventions
Organisme : Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi
ID : TTU-2016-23288
Références
Arch Dis Child. 1970 Dec;45(244):809-10
pubmed: 5491887
Pediatr Infect Dis J. 2003 Jun;22(6):563-4
pubmed: 12828155
Lancet. 1968 Jun 1;1(7553):1167-70
pubmed: 4172289
Trop Med Int Health. 2001 Jul;6(7):529-34
pubmed: 11469946
J Med Virol. 2019 Aug;91(8):1566-1570
pubmed: 31012488
Obstet Gynecol. 2013 Nov;122(5):1139-1140
pubmed: 24150030
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Pediatrics. 2014 Nov;134(5):e1474-502
pubmed: 25349312
Arch Dis Child. 2004 Jan;89(1):52-3
pubmed: 14709507
Bull World Health Organ. 2008 May;86(5):408-16
pubmed: 18545744
J Hyg (Lond). 1977 Jun;78(3):411-7
pubmed: 266541
Pediatr Allergy Immunol. 1996 May;7(2):55-60
pubmed: 8902854
J Korean Med Sci. 2014 Sep;29(9):1325-7
pubmed: 25246755
Am J Prev Med. 2011 Dec;41(6):573-80
pubmed: 22099233
Lancet. 2011 May 28;377(9780):1855-61
pubmed: 21621717
J Glob Health. 2013 Jun;3(1):010401
pubmed: 23826505
Clin Diagn Lab Immunol. 1996 Jul;3(4):477-9
pubmed: 8807217
Jpn J Infect Dis. 2018 Jan 23;71(1):39-44
pubmed: 29279451
Virol J. 2009 Jun 26;6:89
pubmed: 19558656
J Med Virol. 1998 Jul;55(3):234-9
pubmed: 9624612
Asian Pac J Allergy Immunol. 2003 Dec;21(4):269-71
pubmed: 15198345
Vaccine. 2015 Apr 8;33(15):1797-801
pubmed: 25725445
J Clin Virol. 2017 Oct;95:90-95
pubmed: 28903080
J Infect Dis. 2014 Nov 15;210(10):1582-9
pubmed: 24903663